Pharmaceuticals

22 April 2022 by Amy Sandys

Licensing

Court deems Flynn exclusive licensee in Mylan insomnia drug battle

The Court of Appeal in London has ascertained that Flynn is an exclusive licensee of Neurim, overturning a first-instance decision from 2020. But the ...

14 April 2022 by Mathieu Klos

The Netherlands

Hogan Lovells frontman Klaas Bisschop moves to the courts

The well-known patent litigation lawyer Klaas Bisschop has become a judge at the Court of Appeal in Amsterdam. He left the Hogan Lovells partnership a ...

Pennington Manches Cooper patent litigation UK London Dominic Curley

13 April 2022 by Mathieu Klos

Penningtons Manches Cooper expands with patent litigation team

Duncan Curley and his team from Innovate Legal have moved to UK law firm Penningtons Manches Cooper. Curley's previous law firm Innovate Legal was dis ...

8 April 2022 by Amy Sandys

Pharmaceuticals

Sandoz and Teva invalidate blockbuster apixaban patent and SPC

The UK High Court has invalidated a Bristol-Myers Squibb patent, which covers a blockbuster drug and SPC for the treatment and prevention of blood clo ...

30 March 2022 by Amy Sandys

Combination drug SPCs

CJEU to hear SPC referrals in MSD Inegy and Janumet cases

Courts in Ireland and Finland have referred questions concerning Articles 3a and 3c of the current SPC Regulation to the CJEU, to clarify the granting ...

29 March 2022 by Amy Sandys

CMS hires former Herbert Smith Freehills senior partner

International firm CMS Cameron McKenna continues to grow its London patent practice with its second partner hire of 2022. Mark Shillito, formerly a se ...

22 March 2022 by Amy Sandys

Pharmaceuticals

Sanofi and Regeneron prevail as EPO revokes two Amgen patents

The EPO Technical Boards of Appeal have confirmed the revocation of two Amgen patents, following a validity challenge by Sanofi and Regeneron. The two ...

14 February 2022 by Amy Sandys

The Netherlands

Pinsent Masons hires Taylor Wessing partner in Amsterdam

The Dutch office of Pinsent Masons continues its expansion with the addition of life sciences specialist Judith Krens. A former partner and head of li ...

7 February 2022 by Christina Schulze

Pharmaceuticals

Gilead and ViiV Healthcare reach global settlement over HIV drug

Gilead has reached an agreement with patent holder ViiV Healthcare on a licence for its HIV blockbuster drug Biktarvy, ending a global patent dispute. ...

7 February 2022 by Christina Schulze

Germany

Maiwald strengthens team with Isenbruck SPC specialist

Mixed German IP firm Maiwald has strengthened its team with SPC expert Ulrike Herr. She joined in February from Isenbruck Bösl Hörschler, whose Munich ...

18 January 2022 by Amy Sandys

The Netherlands

AstraZeneca and Hoyng avert damages payment to health insurer Menzis

Dutch health insurer Menzis will not receive compensation for unlawful enforcement of a preliminary injunction by pharma giant AstraZeneca. Instead, t ...

6 December 2021 by Konstanze Richter

DLA Piper hires life sciences partner in London

DLA Piper is continuing to grow its London patent practice. The firm is strengthening the team with an additional life sciences partner, Rebecca Lawre ...

15 November 2021 by Christina Schulze

provisional damages, pemetrexed, Eli Lilly, Zentiva, patent litigation

France

French PI over pemetrexed confirmed, but new view on provisional damages

The Paris Court of Appeal has quickly ruled on Zentiva's appeal in the case against Eli Lilly over the cancer drug pemetrexed. It is a win for both si ...